Literature DB >> 19656468

Identification of tumor stem-like cells in a mouse myeloma cell line.

J Dou1, Y Li, F Zhao, W Hu, P Wen, Q Tang, L Chu, Y Wang, M Cao, C Jiang, N Gu.   

Abstract

We used colony formation assay in the soft agar media or the serum-free media, the methods of identifying BrdU-label-retaining cells and the SP cells as well as the tumorigenicity test in BALB/c mice, respectively, to analyze tumor stem like cells in the SP2/0 cell line. The results showed that a few SP2/0 cells were capable of forming colonies in the soft agar media, contained BrdU-label-immortal strand in the SP2/0 cell line. The SP2/0 cells in the serum-free media gained higher tumorigenicity in the BALB/c mice than the SP2/0 cells cultivated in the complete media did. Overall, only a few of the SP2/0 cells were found to possess the characteristics of tumor stem-like cells, such as high proliferative potency, more self-renewal and stronger tumorigenesis, or greater similarity to the tumor stem cells (TSCs) traits. The biology of tumor stem-like cells contributes to the identification of molecular targets important for future tumor therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656468

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  8 in total

1.  Emerging strategies for the identification and targeting of cancer stem cells.

Authors:  Jun Dou; Ning Gu
Journal:  Tumour Biol       Date:  2010-03-25

2.  PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells.

Authors:  Miao Li; Fangfang Shi; Xiong Fei; Songyan Wu; Di Wu; Meng Pan; Shouhua Luo; Ning Gu; Jun Dou
Journal:  Exp Biol Med (Maywood)       Date:  2017-01-01

3.  Homoharringtonine delivered by high proportion PEG of long- circulating liposomes inhibits RPMI8226 multiple myeloma cells in vitro and in vivo.

Authors:  Miao Li; Xiong Fei; Fangfang Shi; Jun Dou; Songyan Wu; Di Wu; Yunxia Zhang; Meng Pan; Shouhua Luo; Ning Gu
Journal:  Am J Transl Res       Date:  2016-03-15       Impact factor: 4.060

4.  MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.

Authors:  Chao Ma; Tao Huang; Yue-Chao Ding; Wei Yu; Qian Wang; Bo Meng; Su-Xia Luo
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles.

Authors:  Fangfang Shi; Miao Li; Jing Wang; Di Wu; Meng Pan; Mei Guo; Jun Dou
Journal:  Stem Cell Res Ther       Date:  2018-05-21       Impact factor: 6.832

6.  MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition.

Authors:  Dengyu Chen; Yunxia Zhang; Jing Wang; Junsong Chen; Cuiping Yang; Kai Cai; Xiaoying Wang; Fangfang Shi; Jun Dou
Journal:  J Ovarian Res       Date:  2013-07-10       Impact factor: 4.234

7.  Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells.

Authors:  Justyna Kutkowska; Leon Strzadala; Andrzej Rapak
Journal:  Int J Mol Sci       Date:  2018-10-19       Impact factor: 5.923

8.  Decreasing Microtubule Actin Cross-Linking Factor 1 Inhibits Melanoma Metastasis by Decreasing Epithelial to Mesenchymal Transition.

Authors:  Xiaoying Wang; Xiao Jian; Jun Dou; Zicheng Wei; Fengshu Zhao
Journal:  Cancer Manag Res       Date:  2020-01-29       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.